Unveiling the epigenetic landscape: transforming renal cell carcinoma treatment
The development and progression of renal cell carcinoma (RCC) are influenced by variety of factors, which pose significant health threats globally.
The development and progression of renal cell carcinoma (RCC) are influenced by variety of factors, which pose significant health threats globally.
It underscores the importance of understanding RCC pathogenesis for improving patient outcomes.
Evidence level: Számítógépes vagy elméleti. Modellből vagy adatbányászatból származó jel.
Related signals
- Prognostic Value of the Modified Glasgow Prognostic Score in Patients with Metastatic Renal Cell Carcinoma Receiving Nivolumab as Second-Line Therapy
- A Review of Immunotherapy in Renal Cell Carcinoma: Current Landscape and Future Directions
- EAU 2025: State-of-the-Art Lecture: Neoadjuvant Strategies in Locally Advanced Renal Cancer
- Early detection of renal cell carcinoma: a novel cell-free DNA fragmentomics‑based liquid biopsy assay
- Merck and Eisai Provide Update on Phase 3 LITESPARK-012 Trial Evaluating First-Line Combination Treatments for Certain Patients With Advanced Renal Cell Carcinoma (RCC)